Monday, June 4, 2012

Cleveland BioLabs (NASDAQ: CBLI); Study Shows Positive Signs

Northern,WI 6/4/2012 (TradersCorner) -- TradersCorner: Cleveland BioLabs Inc. study comes back with a high degree of statistical dose response sending stock up over 60%. Full Disclaimer Here

Distributed by Viestly

No comments:

Post a Comment

Post a Comment